IMPORTANCE Acupuncture is widely used by women undergoing in vitro fertilization (IVF), although the evidence for efficacy is conflicting.
C omplementary therapies are widely used by individuals undergoing assisted reproductive technology. [1] [2] [3] Acupuncture is a frequently used adjunctive treatment during in vitro fertilization (IVF). Acupuncturists from the United Kingdom 4 and Australia 5 indicate use during IVF is a frequent reason for women seeking treatment. Research has focused on evaluating the effects of acupuncture administered prior to and following an embryo transfer. Early studies suggested a potential benefit from acupuncture in improving IVF outcomes [6] [7] [8] ; however, with an increased number of randomized clinical trials (RCTs), evidence of an effect from acupuncture compared with controls has become less clear. Systematic reviews, including a Cochrane review of 14 trials, found no statistically significant difference in clinical pregnancy or live birth rates compared with a control. 9, 10 However, there are significant methodological limitations affecting the quality of evidence. Some trials were at risk of selection bias. All trials reported on clinical pregnancy; only 5 RCTs using sham acupuncture reported on the key outcome of live birth. [11] [12] [13] [14] [15] Overall, the study sample sizes were small, and there was significant study heterogeneity. These limitations have hampered development of recommendations for clinical practice and highlighted the need for a well-designed RCT to address the issues. 9, 10 The objective of this multicenter RCT was to assess the effect of acupuncture vs sham acupuncture during IVF on live birth rates.
Methods

Study Design
Recruitment of eligible women was undertaken at 16 IVF centers in Australia and New Zealand. The trial protocol is available in Supplement 1 and has been published. 16 Ethical approval was obtained from the Western Sydney University Human Ethics Committee and at the respective sites. Women gave written informed consent.
Participants
Inclusion criteria were women aged 18 to 42 years undergoing a fresh IVF or intracytoplasmic sperm injection cycle and not using acupuncture. Exclusion criteria were women undergoing a frozen embryo transfer, previous randomization to the study, planning preimplantation genetic diagnosis, or receiving donor eggs. We made one change to the protocol after commencing the study, which was approved by all ethics committees. We initially included only women with recurrent IVF failure and unsuccessful clinical pregnancies from 4 IVF centers. However, these women were high current users of acupuncture, and in June 2013, following a review by the data and safety monitoring committee, a decision was made to revise the inclusion criteria to increase eligibility to the trial by removing the criteria requiring women to have previous failed IVF cycles and poor treatment outcomes, and to increase the number of recruitment sites. Seventy-eight women who met the study inclusion criteria but declined the trial were invited to participate in a nonrandomized treatment-as-usual group. Data from this group of women will be reported separately. Enrollment commenced June 29, 2011 , and ceased October 23, 2015, due to the end of funding for recruitment. Follow-up of live births was completed in August 2016.
Randomization and Blinding
The randomization sequence was computer generated and was undertaken using the method of minimization 17 stratified by the number of previous embryo transfer cycles (0-1, 2-6, and >6), woman's age (<38 and 38-42 years), and study site. The algorithm was configured to incorporate a window of 3 to minimize forcing of treatment allocations. Allocation concealment was ensured by use of an interactive centralized telephone computer program administered by the National Health and Medical Research Council Clinical Trials Centre, Sydney, Australia. Study participants, fertility specialists and nurses, and the analyst were blinded to group allocation. The clinical trial coordinator and acupuncturists were not blinded to group allocation. Study site research nurses who were blind to group allocation enrolled women into the study and collected clinical outcome data. Blinding was maintained until completion of analysis.
80% group consensus. 18 The treatment strategy was based on traditional Chinese medicine. Acupuncture points were located on the innervation areas to the uterus and ovaries in the abdominal muscles and in the leg to stimulate blood flow to the uterus, and in areas located on the arms and legs that inhibit the central nervous system outflow and the biological stress response. The first treatment involved core points Guilai ST-29, Guanyuan Ren-4, Qihai Ren-6, Sanyinjiao SP-6, and Xuehai SP-10. In addition, up to 5 additional points based on the traditional Chinese medicine diagnosis were selected from a standardized protocol. Manual acupuncture was applied, the needling sensation de qi was attained, and needles were restimulated midway through the 25-minute treatment.
On the day of embryo transfer, an initial treatment was administered within 1 hour prior to embryo transfer and comprised points Guilai ST-29, Diji SP-8, Xuehai SP-10, Taichong LR-3, Guanyuan Ren-4; 1 point from Shenmen HT-7, Neiguan PC-6, or YinTang; and auricular point Zhigong. Following embryo transfer, the second acupuncture treatment was administered including points Baihui DU-20, Taixi KD-3, Zusanli ST-36, Sanyinjiao SP-6, Neiguan PC-6, and auricular point ShenMen. Needles were applied using the Park device, 19 comprised of a plastic ring and a guide tube, with a double-sided adhesive ring to facilitate maintenance of blinding for the participant. The sham control group received noninsertive acupuncture using the Park sham needle supported by the Park device. 19 This needle has a retractable needle shaft and a blunt tip. Acupuncturists were instructed to lightly place the sham needle to the surface of the skin with no manipulation of the needle to minimize any physiological effect. 20 The sham needle can lead to weak physiological effects but has been shown to stimulate different brain activity than acupuncture. 21 To minimize physiological effects, we used sham points at locations away from known acupuncture points and with no known function. 22 Sham points were described in relation to anatomical landmarks. Sham acupuncture was administered at 6 points for each of the treatments. Needle placement duration was the same as for the acupuncture group. 16 Additional details on the interventions, which followed STRICTA guidelines, 23 are provided in eMethods, eTable 1, and eFigure 1 in Supplement 2.
Outcomes
The primary outcome was a live birth, defined as the delivery of 1 or more living infants at greater than 20 weeks' gestation or birth weight of at least 400 g. Prespecified secondary outcomes were miscarriage, clinical pregnancy, anxiety, quality of life, infertility self-efficacy, and adverse events. The definition of clinical pregnancy was amended post hoc to the definition used by the National Perinatal Epidemiology and Statistics Unit, defined as evidence on ultrasonography of an intrauterine sac with or without a fetal heart. 24 The prespecified outcomes quality of life, infertility selfefficacy, and anxiety are not reported in this article. Post hoc secondary outcomes included total dose of follicle-stimulating hormone, numbers of oocytes aspirated and fertilized, stage of embryo development at transfer, pregnancy loss (defined as termination, ectopic pregnancy, stillbirth, and neonatal death), gestational age, birth weight, congenital abnormality, and days in the nursery of the infant. Clinical outcomes were collected when the outcome of the IVF cycle was known and continued until delivery. Adverse events from the intervention were collated from the acupuncturists and from women completing self-report questionnaires following embryo transfer and at 2 and 14 weeks from trial entry.
Baseline characteristics, including sociodemographic characteristics, were collected to describe the diversity of the study population. Race/ethnicity was assessed using predetermined fixed options and determined by the participant. Blinding to group allocation was assessed through questioning participants about their perceived group allocation following the last treatment and at 2 weeks after embryo transfer. Blinding was assessed using the Bang blinding index. 25 This index is scaled to an interval of −1 to 1, with 1 being complete lack of blinding, 0 being consistent with perfect blinding, and −1 indicating guessing.
Study Power
Combining pilot data, evidence from the systematic reviews and clinical advice, we estimated that a 7-percentage point or greater increase in the proportion of live births would be clinically important. 8, 10 To obtain 80% power at a 5% significance level for a 2-sided test, we assumed a proportion of 13.4% 8 live births in the control group and 20.4% live births in the acupuncture group, requiring 449 participants per group. We estimated 30% attrition from the study, with loss arising from canceled cycles or no embryo transfer and study withdrawal. In total, 1168 women were required.
Statistical Analysis
An intention-to-treat analysis was planned; however, analysis was performed on a cohort excluding women who withdrew consent for use of their data and excluding those for whom data on live birth were not available. The characteristics of the women randomized to each treatment group were summarized using counts and percentages for categorical variables and means and SDs for numeric variables.
For the primary analysis, we first compared the proportions of women with live births or each secondary outcome in the 2 groups for all participants using risk differences (RDs) and relative risks (RRs) with associated 95% CIs and a hypothesis test for no effect. Twenty-four women no longer met the inclusion criteria between randomization and commencement of IVF treatment (ie, conceived naturally or discontinued IVF) and were classified as postrandomization exclusions. However, we were able to obtain data on live births for 9 of these women, and on clinical pregnancy from 14 women. These data were included in the analysis of these outcomes.
To assess the effect of missing data, we performed post-hoc sensitivity analyses, fitting best-and worst-case scenarios. For the best-case scenario, we assumed all unknown events in the acupuncture group were positive (live birth, successfully pregnant) and those in the sham acupuncture group were negative. For the worst-case scenario, we assumed none of the women with missing data in the acupuncture group became pregnant, and all of the women with missing data in the sham acupuncture group did become pregnant. A post-hoc-adjusted analysis was performed for the stratification variables using a log-binary mixed model with study center as a random effect. Exploratory analyses investigated the differences between study centers in the risk of live births visually as a forest plot with the associated I 2 statistic quantifying the level of unexplained variation between centers.
We performed an exploratory per-protocol analysis examining the outcomes for women undergoing an embryo transfer (excluding women with canceled cycles). In this group, we also investigated the influence of potential outcome modifiers including cleavage vs blastocyst embryo stage of development, previous number of IVF cycles, and number of treatment sessions received on selected clinical outcomes between study groups. The number of treatment sessions attended was classified as those with 0 to 1 vs 2 or more, reflecting a maximum of 3 treatments administered, 2 of which were delivered on the day of embryo treatment. No adjustment was made for the multiple comparisons undertaken in the post-hoc analysis. Two-sided P < .05 indicated statistical significance. SAS version 9.4 (SAS Institute) and STATA 14 (StataCorp) were used for statistical analyses.
An independent expert data and safety monitoring committee met annually to monitor safety and advise on trial design decisions. This committee was composed of independent members with clinical and statistical expertise who had no conflicts of interest and no involvement in the running of the trial. The data and safety monitoring committee charter included prespecified stopping rules. Because of slow recruitment, an unplanned futility analysis of all clinical outcomes was undertaken in July 2015. Advice from the committee was presented to the study investigators, and a recommendation was made to continue to the end of funding period for recruitment.
Results
A total of 848 women intending to undergo a fresh IVF cycle were randomized to the trial (424 acupuncture; 424 sham control) by the end of the funding period (Figure) . Twenty-four women withdrew consent for their data to be used in the analysis. Prior to receiving their first study treatment, 24 women were excluded due to noncommencement of their IVF cycle or insufficient English to complete all measures. Some data became available from these 24 women (9 for live births and 14 for clinical pregnancy). Data were analyzed from 809 women (405 acupuncture; 404 sham control) for the primary analysis of the primary outcome of live birth and from 824 women (415 acupuncture; 409 sham control) for the sensitivity analysis. Data were analyzed from 814 women (408 acupuncture; 406 sham control) for the analysis of the secondary outcome of clinical pregnancy and from 824 (415 acupuncture; 409 sham control) for the sensitivity analysis. Cancelation of the IVF cycle (failed stimulation, no oocyte retrieval or embryo transfer) was reported for 193 women. Therefore, 607 women received the intended treatment of embryo transfer (301 acupuncture; 306 sham control).
Baseline demographics are shown in Table 1 and were balanced between groups. The mean (SD) age was 35.4 (4.3) years, 245 women (29.7%) underwent their first IVF cycle, and 588 women (71.4%) had experienced infertility for longer than 2 years. The delivery of treatments by acupuncturists was balanced between groups. Adherence to the intervention by women was balanced between groups, 538 (65.5%) received 3 treatments, 32 (3.9%) received 2 treatments, and 210 (25.5%) received 1 treatment only. Seventyeight acupuncturists provided a median of 8 treatments to the treatment group, and 82 acupuncturists provided a median of 7.5 to the sham control group. 
Exploratory Analysis
In a post hoc exploratory analysis, we examined the primary and secondary outcomes for 607 women undergoing embryo transfer only (eTable 3 in Supplement 2). We found no statistically significant difference in live births and clinical pregnancies between groups of women undergoing a cleavage or blastocyst transfer, 2 or more previous IVF cycles, undergoing IVF for the first time, with 1 previous IVF cycle, or 2 or more or 0 to 1 treatment sessions attended. Adherence to the intervention was high, with 557 women (91%) receiving 2 or more treatment sessions.
Treatment Blinding
A total of 180 women (43%) in the acupuncture group and 142 women (34%) in the sham control thought they received acupuncture, and 168 women (41%) in the sham acupuncture group correctly guessed their group allocation (eTable 4 in Supplement 2). The Bang blinding index suggested women were unblinded in the acupuncture group a Adjusted analysis was performed using a log binary mixed model with the stratification variables (woman's age and number of prior in vitro fertilization cycles) as fixed effects and study center as a random effect.
b Assuming all unknown events in the acupuncture group were positive and those in the sham acupuncture group were negative.
c Assuming none of the women with missing data in the acupuncture group became pregnant, and all of the women with missing data in the sham acupuncture group did become pregnant. (0.18; P < .001) but not in the sham control group (0.064; P = .14). The significant unblinding in one group but not the other group is suggestive of an overall response bias. 25 A small response bias was found following treatment, with participants believing they were more likely to have received an active treatment rather than a sham treatment (z = 2.086; P = .04), but this was not significant at 2 weeks following embryo transfer (z = 1.96; P = .057). The response bias index remained below the 2 absolute criteria indicating no response bias between the groups.
Discussion
In this randomized clinical trial involving women undergoing IVF, administration of acupuncture vs sham acupuncture around the time of ovarian stimulation and embryo transfer did not result in statistically significantly different live birth rates over 1 year. These findings, along with the finding of no statistically significant increase in clinical pregnancies, do not support the use of acupuncture to improve birth outcomes among women undergoing IVF.
Findings from this trial support a recent guideline from the American Society for Reproductive Medicine 26 and
2 high-quality meta-analyses 9,10 that found that acupuncture compared with a sham control performed around the time of ovarian stimulation and embryo transfer does not improve live birth rates in IVF. A similar finding of no increase in live births was reported from an RCT of 1000 Chinese women with polycystic ovary syndrome undergoing 4 cycles of ovulation induction following acupuncture. 27 The safety of acupuncture as assessed by miscarriage is supported by the findings from the Cochrane systematic review 10 and from studies examining outcomes from acupuncture when administered during pregnancy that find no evidence that acupuncture poses any risk to the mother or unborn fetus. 28 Mild acupuncture-related adverse events were reported and differed between groups. The profile of these adverse events are similar to those reported in reviews assessing the safety of acupuncture in pregnancy and in the wider population. 28, 29 The adverse events may have contributed to the finding of partial unblinding. The study addressed whether acupuncture was more efficacious than a placebo and specifically examined whether any effect was mediated through the point-specific needle insertion. To do this, a noninsertive needle was used. A recent meta-analysis examining placebo devices as effective control methods in acupuncture clinical trials 30 found that these devices are not necessarily inert control interventions. These findings therefore may be explained by potential activity from the sham control. To determine whether any treatment effect in clinical outcomes arises from point-specific needle insertion or from other nonspecific effects, such as the placebo or time and attention from a therapist, would require the inclusion of a no-adjuvant treatment group in the trial design. A usual care-alone group was not included in the RCT due to findings from a previous pilot study 8 that women would decline randomization to this design. Therefore, it remains unclear whether there are nonspecific effects from acupuncture or a sham control.
The main strengths of this study were its size, the multicenter design involving fertility units across Australia and New Zealand, and high rates of follow-up and adherence. The treatment protocol was based on best practice and was developed achieving consensus from expert clinicians; it also has broad generalizability to the practice of acupuncture. Blinding was intact in both groups, with the value of less than 2 indicative of unblinding due to a response bias not met by the acupuncture group. 25 
Limitations
This study has several limitations. First, the planned sample size was not achieved. Women increasingly accessed acupuncture in the community and declined randomization to the study. In response to the slow trial recruitment, the number of sites was increased to 16 IVF units to facilitate recruitment and the restrictive eligibility criteria reduced after 302 women were randomized. The 95% CI of the risk difference for live births excluded the minimal clinically important difference of 7%, suggesting the study was not underpowered. Second, the stage of embryo transfer was not balanced between groups, with a significantly higher number of women undergoing blastocyst transfer in the control group. This is a possible limitation due to blastocyst stage embryo transfer being associated with higher rates of pregnancy and live birth than cleavage stage transfers. 31 No explanation for this observation was found and this could have occurred through chance. Third, the length of the treatment intervention was short. However, earlier clinical trials in which acupuncture was administered only at the time of embryo transfer have reported improved live birth rates while using this short intervention. 6, 32 In clinical practice, acupuncture treatment is individualized with variation in the dosing characteristics of acupuncture, including more frequent treatment prior to and during the IVF cycle. 18 Fourth, women were unavoidably excluded from the intention-to-treat analysis due to withdrawal of consent. In retrospect, tighter inclusion criteria and randomization closer to the onset of the stimulation cycle may have prevented study withdrawals. However, due to the small differences in outcomes, a full intention-totreat analysis is unlikely to have changed the results. Fifth, multiple secondary outcomes were investigated without correction for multiple comparisons and these analyses should be interpreted as exploratory.
Conclusions
Among women undergoing IVF, administration of acupuncture vs sham acupuncture at the time of ovarian stimulation and embryo transfer resulted in no significant difference in live birth rates. These findings do not support the use of acupuncture to improve the rate of live births among women undergoing IVF. Despite the significant personal costs of ART, over the last five years, the number of ART procedures has increased on average by 10% per year in Australia 1 . In fact, Australia has one of the highest levels of utilization at 1,574 cycles per million population, and with the average cost of a standard IVF cycle at $5,549 IVF is a resource intensive and costly treatment option for both women and their families and for public health care expenditure. Therefore new therapies that improve reproductive outcomes are highly desirable.
The use of acupuncture by women undergoing IVF
Complementary medicines and therapies (CM) are concerned with both the maintenance of wellness and the treatment of illness. CM is widely used in the community, during 2007 over 60% of Australians reported using CM, and 44% had visited a CM practitioner 5 . Studies indicate that CM are widely used by women to enhance their fertility. In one survey of CM use by patients attending an IVF unit in Adelaide, 45% of men and women continued to use CM during their ART treatment. The study found use of many CM modalities declined during ART, however the use of acupuncture increased 6 . This may be explained by women's awareness of research evaluating the effect of acupuncture as an adjunct to IVF.
There is a growing body of research evaluating the effect of acupuncture administered during IVF, and specifically on the day of embryo transfer (ET). One of these trials was undertaken by CI Smith 7 addressed a significant methodological flaw in previous studies by using an appropriate control (the placebo needle). Our trial randomised 228 women to acupuncture or a control group using the placebo needle. The first treatment was administered on day 9 of the stimulated cycle, and two treatments administered before and after ET. The clinical pregnancy rate was 31% in the acupuncture group vs 23% in the control group (p<0.18), (OR 1.51, 95% CI 0.84 to 2.72), and the ongoing pregnancy rate at 18 weeks was 28% in the acupuncture group compared to 18% in the control group (OR 1.71, 95% CI 0.92 to 3.19, p<0.08). The trial may have been under-powered but a treatment effect can not be excluded.
A review of the evidence of acupuncture RCTs undertaken on the day of ET:
We present an updated review and meta-analysis of RCTs undertaken on the day of ET to examine the effect on reproductive outcomes. We have included published trials (up to February 2010) comparing acupuncture to a control group, and reported on a clinical pregnancy, or live birth. Trials of manual and electro-acupuncture were included. Exclusion criteria included laser acupuncture, cross over trials, and the trial intervention administered a significant distance off site from the IVF unit. The meta-analysis pooled data from all trials and uses a random effects model. Two trials were excluded from this review 14, 15 ; one trial performed acupuncture at a distance offsite, and one trial reported inadequate randomisation.
Nine RCTs with a total of 1,882 women met our inclusion criteria [7] [8] [9] [10] [11] [12] 14, [16] [17] . Internal validity was high for all trials with adequate allocation sequence generation, and randomisation concealment was judged as adequate in eight trials. There was no imbalance at randomization for all trials. Blinding was successfully maintained in groups using the placebo needle or sham control. There were losses to follow up in two trials [11] [12] . However, not all trials report on the key outcome of live birth, sample sizes were small and trials were underpowered to detect statistical differences between groups, and inadequate controls have been used to examine the efficacy of acupuncture. These study design limitations impacted on the findings from a meta-analysis of data. Nine trials 7-12, 14, 16-17 (1,882 women) reported on clinical pregnancies. Data were pooled due to the heterogeneity by control group design. The meta-analysis found insufficient evidence of a benefit from acupuncture with improving clinical pregnancy rates (OR 1.35, 95% CI 0.96 to 1.90 P=0.08), however there was significant heterogeneity (Figure 1 ). Significant heterogeneity was explained by one trial undertaken by So 17 ,where the design of the control group stimulated active points and was not inert. Excluding this trial from the meta-analysis reduced the heterogeneity (I 2 =30%), and a benefit was found from acupuncture (OR 1.53 
, 95%1.17 to 2.01, p<0.002).
Only five trials 7, 9, 10, 11, 17 (1255 women) reported on live births. The forest plot shows a trend towards an increase in live births for the acupuncture group, although it did not reach significance (OR 1.53, 95% CI 0.91 to 2.59 P=0.11) (I 2 =74%) (Figure 2 ). Excluding the So trial reduced heterogeneity (I 2 =0%), and a benefit from acupuncture on live births was found OR 1.91, 95%CI 1.39 to 2.64, P=0.001). The findings from our meta-analysis and published systematic reviews 18, 20 indicate acupuncture may have a beneficial effect on reproductive outcomes, however results are influenced by small samples and in adequate controls. Implications for practice cannot be made until acupuncture has proven efficacy and shown to be more effective than a placebo.
Can the effect of acupuncture on reproductive outcomes be explained biologically? Mechanisms underlying acupuncture have been widely researched in relation to pain. Acupuncture analgesia research suggests acupuncture triggers a sequence of events involving the release of endogenous opioid like substances, for example -endorphin, and enkephalin that modulate pain signals 21 . Further, imaging technology studies show the hypothalamus-limbic system plays a role with acupuncture analgesia by modulating sensory and emotional aspects of pain processing. Mechanisms underlying other health conditions may involve modulation of the autonomic nervous system, as seen in patients with irritable bowel syndrome and major depression 22 . Electro acupuncture has been shown to release ß-endorphin a neurotransmitter and neuro hormone via two systems 23 . One system involves the hypothalamus and neuronal network which results in an inhibitory effect on the vasomotor centre resulting in decreased sympathetic tone. Secondly, ß-endorphin released into the blood may exert an effect on both the hypothalamicpituitary axis and hypothalamic-pituitary-gonadal axis and may have an effect on gonadotropinreleasing hormone (GnRH) and pituitary gonadotrophin secretion 24, 25 . Acupuncture may exert a sympatho-inhibitory effect reducing uterine artery impedance and increase uterine and ovarian blood flow. Improved blood flow in women undergoing the down regulation phase of IVF from acupuncture has been reported 26 . This improved blood flow could hypothetically improve the growth and thickness of the endometrium and endometrial receptivity. To date these findings have not been confirmed in controlled studies 27 .
The personal and social context of acupuncture
Studies suggest psychological factors may influence successful outcomes from IVF 28, 29 . Ebbsesen et al found a large number of life events perceived as having a negative impact on quality of life may indicate chronic stress, and this may reduce the chances of a successful outcome from IVF 29 . In addition, the stress associated with IVF treatment may invoke anxiety, and affect feelings of self worth, loss and potentially depression. Research shows that distress among women undergoing IVF increases over time 30 , and peaks between the second and third year 31 . Longitudinal studies show that unsuccessful IVF has substantial psychosocial consequences, with anxiety and depression found to increase in women following unsuccessful treatment 32 . Acupuncture may have a calming effect at the time of ET and so elicit beneficial effects. The mechanism for this may be through reducing synthesis of stress hormones, now recognised to impact on pregnancy success. This suggestion is supported by data from our RCT showing a relaxation effect following acupuncture on the day of ET 8 . CIs Smith and de Lacey recently reported on an exploratory qualitative research examining women's experiences following a course of acupuncture as an adjunct to ART [4] 33 . Our findings suggest acupuncture may provide properties of self enhancement such as increased confidence, clarity and wellbeing, enhanced coping and adaptation and encouraged positive emotion and provided social support 33 . Women reported feeling relaxed, less stressed and an increased capacity to cope for about a week after treatment. If the effects of acupuncture are sustained over a week as indicated by our research, our treatment hypothetically could reduce women's distress in the period leading up to the pregnancy test, and more immediately around the time of implantation thus minimizing the impact of stress on implantation. A recent study in Melbourne in which focus groups were conducted with women having CMs reported similar experiences of psychosocial support for women 34 . We also have data from uncontrolled and controlled studies showing a short course of acupuncture for women undergoing ART demonstrated improved self efficacy and coping skills 35, 36 1.2 RATIONALE FOR STUDY There is a need for further appropriately powered, well designed RCTs evaluating the role of acupuncture on live birth. Whilst international clinical trial registries indicate four RCTs are in progress, the effect of acupuncture on live births will remain unanswered.  The primary endpoint of these trials is clinical pregnancy, with sample sizes ranging from 60-635, trials will not be powered to detect a statistical effect on live birth.
 The two largest RCTs compare acupuncture with either the placebo needle, or sham needle or standard care alone, therefore determining the efficacy of acupuncture compared with an optimal placebo control, and standard care with improving live births will remain unanswered.
There are clearly methodological concerns with the experimental design of ongoing trials, none of which will adequately address the methodological limitations of previous acupuncture research. There is a need for a further appropriately powered well designed RCT using of the placebo needle to enhance the quality of the studies, and standard care group to allow for a comparison with the baseline pregnancy rate. 
STUDY OBJECTIVES
ENDPOINTS 2.2.1
Primary study endpoints: Proportion of women reporting a live birth defined as the delivery of one or more living infants, greater than 20 weeks gestation or 400grams or more birth weight.
2.2.2
Secondary study endpoints Proportion of women reporting a clinical pregnancy defined as demonstration of fetal heart activity on ultrasound scan, measured at 7-8 weeks, miscarriage defined as a non viable pregnancy prior to 12 weeks, quality of life and fertility related stress, and anxiety measured at trial entry, two and 14 weeks from trial entry. Acceptability of acupuncture and therapeutic alliance measured at the end of the intervention.
STUDY DESIGN
1. A single blind randomised controlled trial of acupuncture during IVF treatment. 2. Qualitative interviews with women selected from the sampling frame of the RCT.
3. An economic analysis to determine the cost effectiveness of acupuncture as an adjunct to IVF.
4. An integrated analysis of the findings from all studies.
STUDY POPULATIION 4.1
NUMBER OF PARTICIPANTS 1. The proportion of women with a live birth for women with multiple cycle failures in the placebo control group in our previous study was 12.1% 8 . To detect a 7% increase in the proportion of women that report a live birth between the treatment and placebo control, with 80% power at the 5% significance level will require 449 women per group. We have allowed for a loss of 30% due to cancelled cycles, or no ET. A sample size of 1168 women is required.
2. We expect a larger treatment effect (10%) when comparing acupuncture and standard care. Allowing for a 30% loss, 231 women in the non randomised group will have 80% power to detect a difference in the proportion of women that report a live birth rate compared to the acupuncture group.
INCLUSION CRITERIA Entry criteria:
Women aged less than 43 years, undergoing a fresh IVF or ICSI cycle.
4.3
EXCLUSION CRITERIA Women undergoing a frozen ET, previous randomisation to the trial, planning pre-implantation genetic diagnosis, or receiving donor eggs, or having current acupuncture use.
PARTICIPANT SELECTION AND ENROLMENT
5.1
IDENTIFYING PARTICIPANTS The recruitment strategy will include self referral or referral from clinicians. The recruitment strategy will include for example networking with medical specialists and clinicians at the IVF units, and placement of information on internet web sites of the research institutions.
5.2
SCREENING FOR ELIGIBILITY Recruitment will be undertaken by research nurses or a trial co-ordinator employed at the IVF Unit. Research nurses or the trial co-ordinator will disseminate information to clinical staff, and seek referrals from clinicians. Potential women will also be screened from appropriate clinic listings Eligible women will be screened by the research nurses/ trial co-ordinator. Women meeting the criteria will be invited to consent to the trial on day 6-8 of the stimulated cycle. Women refusing randomisation will be invited to join the standard care group.
If women are eligible and interested in joining the study, an appointment will be made. The research nurse/co-ordinator will confirm this in writing with an email, phone or by post. A map will be provided and details of the acupuncture location will be confirmed.
5.3
CONSENTING PARTICIPANTS Following consent, a trial entry form will record information on reproductive, clinical, demographic and socio-economic characteristics.
INELIGIBLE AND NON-RECRUITED PARTICIPANTS
A log will be made of women who do not meet the eligibility criteria. The reason must be recorded on the log sheet.
If women are not interested in joining the trial, the reason for declining should be logged.
RANDOMISATION
5.5.1 Randomisation Randomisation will be in balanced, variable blocks. Women will be allocated to a study group by an internet randomisation service, prepared and based at the NHMRC Clinical Trials Centre. There will be stratification by number of ET cycles (0-1, 2-6 and 6+), woman's age (<38, and 38-42 years), and collaborating centre. Randomisation will be into two study groups, acupuncture and a sham control. If a woman declines randomisation and she wishes to contribute data to the trial she will be allocated to the non randomised cohort arm of the study.
Treatment Allocation
Randomisation will be into two study groups, acupuncture, and sham acupuncture.
Emergency Unblinding Procedures
CI Smith is responsible for requesting emergency unblinding. The study randomisation code will only be unblinded if there is a serious medical or safety reason. For example, a serious adverse event. In an emergency Ros Priest on 0449258902 should be contacted for unblinding. CI Smith will document the unblinding in a case report file.
Withdrawal procedures
If a participant expresses a desire to withdraw from the trial they can withdraw immediately. Treatment will cease in the two acupuncture groups.
Women will be requested to complete the measurement at the nearest time point following the last treatment.
If a subject withdraws during the intervention they will not be replaced. If they withdraw immediately following randomisation they will be replaced.
INVESTIGATIONAL THERAPY AND CONTROLS
Following randomisation women will see the acupuncturist based at the IVF centres, or at close proximity to the centres. Women will undergo a traditional Chinese medicine (TCM) diagnosis. The diagnosis and treatment will follow an agreed algorithm and will take 60-90 minutes 38 . This treatment will be administered day 6-8 of the stimulated cycle. Two subsequent treatments will be administered for 25 minutes on the day of ET, before and after ET.
ACUPUNCTURE
The initial treatment will be given according to a TCM diagnosis and will be based on an individualized treatment protocol. On the day of ET the acupuncture treatment based on the Paulus protocol 7 will be used. The first ET treatment will use: Pericardium 6, Spleen 8, Liver 3, Stomach 29, Conception Vessel 6 and Governing Vessel 20, and four auricular (ear) points. The second ET treatment will use acupuncture points Stomach 36, Spleen 6, and Spleen 10, and the same auricular points. The rationale for points used on the day of ET include points which regulate immune system responses in general, these include Stomach 36 and Colon 4, and reduce uterine contractility Spleen 6 and Spleen 10. The acupuncture points on the ears relate to the uterus and endocrine system and stimulate specific parts of the hippocampus. Other points relax the woman. Acupuncture will be applied bilaterally, with the exception of the ear points, where two points will be needled in the right ear, and the other two points needled in the left ear before treatment. Acupuncture needles will be inserted to tissue level and stimulated manually. The needles will be stimulated once more during this treatment session. There is little divergence in the published literature with respect to the frequency and stimulation of points for this treatment on the day of ET. Single-use disposable stainless steel needles (0.25 x 40mm for body acupuncture) will be used. All points will be located according to standard texts.
Sham control
The control group will use the Park sham needle 39 which has a retractable needle shaft, a blunt tip, skin penetration does not occur, and the needles have a supporting device. The acupuncturist will hold the "needle" in place with one hand, while moving the handle of the needle with the other hand, so the shaft disappears into the handle. The placebo needle will be placed away from acupuncture points and the protocol describing the location of these points used will be from our earlier research 8 . The Park needle is an effective device for blinding in RCTs 39 . A protocol will describe the location of non acupuncture points, these will be located away from the segmental location of the real points. Trials procedures as described for the real acupuncture group regarding duration, and interaction with the practitioner will be the same as for the placebo control group.
6.3
Standard care Women will continue as normal. Consent will have been given to collect clinical outcome data and for women to complete the health economic diary (see below).
6.7
Prior and Concomitant Medications 6.7.1 Permitted Medications Subjects will continue with all prescribed medication.
STUDY ASSESSMENTS 7.1
SAFETY ASSESSMENTS Participants receiving the study intervention will be asked about how they are feeling at the start of each study intervention. Any adverse events or reactions associated with the intervention will be recorded on the patient case report file and to the principal investigator CI Smith. The investigator will exercise her scientific judgement in deciding whether an abnormal finding or other abnormal assessment is clinically significant. All adverse events (AE/SAE ) reported between consent and final follow-up will be recorded in the adverse event page of case report form (CRF), regardless of relatedness to the study intervention. A safety monitoring committee will be convened to examine events.
7.2
STUDY ASSESSMENTS Primary and secondary endpoints will be assessed at baseline, at 2 and 12 weeks. Clinical outcome data will be collected following the blood HcG test, clinical ultrasound and live birth.
Access to PBS and Medicare will be undertaken at the end of the study for all those women providing consent.
A sample of women from all sites will be invited to participate in an in-depth interview once the results of their pregnancy test are known.
DATA COLLECTION
The research nurse/co-ordinator employed at the IVF Unit will be responsible for data collection of the reproductive outcomes. This data is collected routinely by all IVF units. To ensure data collection on live births is timely, we will seek the women's permission to contact her following her expected date of delivery. Contact details will be collected from the woman and nominated contacts to advise on change of address, three monthly phone calls will be made to maximize retention and loss to follow up, this will be done by the trial co-ordinator.
The research nurse/co-ordinator will be responsible for administering questionnaires designed for self-completion at baseline. The trial co-ordinator will liaise with the research nurses at two and 14 weeks from trial entry to arrange posting of other repeat questionnaires. Women's quality of life will be assessed using the MOS Short Form 36 (SF36). The SF36 is the most widely used health status measure in the world and yields scores across eight health dimensions and two summary scores relating to physical and mental health 40, 41 . The SF-6D scoring algorithm will be applied to generate utilities from responses to the SF-36 42 . To assess coping skills women will also be asked to complete the valid and reliable Infertility Self-Efficacy Scale 43 . It consists of 16 items that probe into the respondents perceptions about their ability to deal with various aspects of fertility treatment. The fertility problem inventory will assess fertility related stress and the STAI used to assess anxiety.
STATISTICS AND DATA ANALYSIS 9.1
PROPOSED ANALYSES Data will be analysed by a statistician based at UWS. The statistician blind to study group will examine the reproductive, demographic and baseline characteristics of trial participants, and for imbalances at randomisation. Any imbalances at randomisation will be adjusted for in subsequent analysis. The analyses of the endpoints will undertake an 'intention to treat' approach and compare differences in the primary and secondary outcomes between groups. Comparisons of the primary and secondary endpoint will be made between groups by constructing odds ratios, and 95% confidence intervals based on differences in proportions between groups, and the number needed to treat. Sub group analyses will be stated a priori, for example influence of stimulation doses, long or short acting stimulation cycle. Levels of significance will be reported at p<0.05.
MONITORING AND QUALITY ASSURANCE
10.1
PROJECT MANAGEMENT AND TRIAL MANAGEMENT GROUP A monthly management teleconference will be held with investigators and partners to examine trial recruitment accrual, data quality, compliance with the protocol and organization and implementation of the trial protocol. A data monitoring and safety monitoring committee will be established consisting of independent researchers/advisors to examine data for evidence of harm (e.g cancelled cycle). 
GOOD CLINICAL
eMethods. Protocol Treatment Interventions
Following randomization women in the intervention groups arranged an appointment with the study acupuncturist based at the in vitro fertilization (IVF) centers, or at close proximity to the IVF centers. The acupuncturists were registered with a national professional association, and were required to have a minimum of two years clinical experience.
The treatment protocol used in the study was developed using a Delphi method, with treatment characteristics retained on reaching 80% group consensus. Two rounds of the Delphi process, achieved a 80% consensus to be achieved for individual items to be included in the treatment protocol 1 . Nineteen acupuncturists participated in this process, with practitioners from Australia (6), China (2), Denmark (1), Sweden (1), the United States (4), and the United Kingdom (1).
The first visit to the acupuncturist was undertaken on days 6 to 8 of the stimulated IVF cycle. At this initial visit all women underwent a traditional Chinese medicine diagnosis, by the study acupuncturist. The initial diagnosis and treatment too k60 to 90 minutes. Two treatments were subsequently administered immediately before and after the day of the scheduled embryo transfer. No other treatments other than acupuncture were administered during the study visits.
Acupuncture Group First treatment
Treatment was based on the traditional Chinese medicine style of acupuncture. All standard acupuncture points were used 2 . The initial treatment included five core points administered to all women in the treatment group comprising of: Guilai ST-29, Guanyuan Ren-4, Qihai Ren-6, Sanyinjiao SP-6, Xuehai SP-10. Up to five additional points based on a traditional Chinese medicine pattern differentiation could also be administered. The treatment protocol detailed additional points to be administered for the study participant from the following traditional Chinese medicine syndromes: Manual acupuncture was performed with disposable stainless needles (0.22x40mm, 0.20x12mm Vinco) inserted. Needles were inserted using the Park device, a supporting tube that facilitates maintenance of blinding for the participant. Needles were inserted to a depth of not greater than 2 cm and retained for 25 minutes at each treatment. The insertion of the acupuncture needle into an acupuncture point typically generates a range of sensations called 'de qi', this sensation was maintained during the initial treatment on days 6 to 8, and during the pre-embryo treatment only. Needles were inserted into points bilaterally except for the acupuncture points located on the Ren and Du points and YinTang 2 . The results for each site are presented as unadjusted risk differences with 95% confidence intervals. The size of the data markers is proportional to the relative weight of information (sample size and inverse variance) of each site. The individual risk differences are combined using a random effects model fitted using the method of DerSimonian and Laird. Heterogeneity between sites is described by the I 2 statistic which indicates the percentage of variation between the studies which is due to heterogeneity rather than due to chance. Values above 50% are often interpreted as indicative of clinically important heterogeneity. This is accompanied by a Cochran's Q chi-squared test for homogeneity where p-values less than 0.05 indicate statistically significant evidence of heterogeneity between sites. mean and SD c n=397 acupuncture group (5 missing data and 1 woman with 0 FSH excluded), n=401) sham acupuncture control 2 missing data d women undergo a transfer of 1 or 2 embryos only at the recruiting sites. e 12/415 women did not proceed with IVF (3 were pregnant, 3 converted to IUI, 2 had unrelated health issues, 4 changed their minds) f 6/409 women did not proceed with IVF (3 were pregnant, 3 changed their mind) g n=403 n=402, (one missing in sham acupuncture control group) h pregnancies due to IVF are 101 in the acupuncture group and 86 in the sham acupuncture group i births due to IVF are 73 in the acupuncture group and 72 in the sham acupuncture group j unless otherwise specified, this tests the hypothesis that relative risk is equal to 1. k independent samples t-test testing the hypothesis that the means are equal l Pearson's chi-square testing the hypothesis of no association with treatment group m Mean difference
